SCM
ALT icon

Sterling Capital Management’s Altimmune ALT Stock Holding History

Sterling Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61K Buy
847
+317
+60% +$1.35K ﹤0.01% 2931
2025
Q4 		$1.91K Buy
530
+333
+169% +$1.45K ﹤0.01% 3072
2025
Q3 		$743 Buy
197
+10
+5% +$39 ﹤0.01% 3120
2025
Q2 		$724 Sell
187
-412
-69% -$2.23K ﹤0.01% 3109
2025
Q1 		$3K Sell
599
-479
-44% -$3.03K ﹤0.01% 2412
2024
Q4 		$7.77K Buy
1,078
+935
+654% +$7.14K ﹤0.01% 2274
2024
Q3 		$878 Buy
+143
New +$969 ﹤0.01% 2601

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Sterling Capital Management's ALT Position: Q1 2026 in Review

Sterling Capital Management increased its Altimmune (ALT) stake by 60% in Q1 2026, buying an estimated $1.35K and bringing the position to 847 shares worth $2.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2931.

Sterling Capital Management first reported a position in ALT in Q3 2024 and has held it in 7 quarters since. The position peaked at $7.77K in Q4 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Sterling Capital Management held 847 shares of Altimmune worth $2.61K as of Q1 2026.
  • Sterling Capital Management bought 317 Altimmune shares in Q1 2026, an estimated $1.35K.
  • Altimmune made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2931 holding.
  • Sterling Capital Management first reported a position in Altimmune in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Altimmune position peaked at $7.77K in Q4 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.